ABSTRACT The presence or absence of venous
Pulmonary thromboembolism is a common finding at postmortem examination of patients with chronic obstructive lung disease' 2; the role of thromboembolism, however, in the precipitation or evolution of acute exacerbations of chronic obstructive lung disease and in the pathogenesis of the pulmonary hypertension seen in this disorder is unknown. The diagnosis of pulmonary embolism -in patients with significant chronic obstructive lung disease is difficult; physical signs are usually unhelpful; lung scans may be difficult to interpret and even pulmonary angiography may fail to show small emboli.3
Although it has been suggested that pulmonary emboli in patients with chronic obstructive lung disease may originate in the right ventricle of the heart' at least a proportion of pulmonary emboli are likely to originate from the pelvis and lower extremities, as is the case in other groups of patients. 45 We have attempted to define the frequency of deep venous thrombosis in patients admitted to hospital with an exacerbation of chronic obstructive lung disease using the indium-111-labelled platelet technique.6
Patients and methods Twenty-nine patients with an exacerbation of chronic obstructive lung disease were enrolled into the study. These subjects were patients admitted to the thoracic medicine wards of the Aberdeen hospitals. The patients were enrolled consecutively except during periods when the investigators were absent or when the indium labelling technique was not available.
The diagnosis of chronic obstructive lung disease was based on the following: a history of cigarette smoking, winter bronchitis, and dyspnoea progressing over several years; obstruction of the airways indicated by a ratio of forced expiratory volume in one second to forced vital capacity (FEV,/FVC) of less than 70%; and no significant reversibility of the obstructive defect (increase of FEV, by more than 15% in response to inhalation of a ,-agonist drug by aerosol) either during the study admission or during a previous admission to hospital. An exacerbation of chronic obstructive lung disease was defined as an increase in the severity of respiratory symptoms resulting in hospital admission. All patients received physiotherapy and treatment with controlled oxygen, antibiotic drugs, nebulised bronchodilator agents, and bed rest. Eighteen patients received treatment with corticosteroid drugs and 22 were treated with diuretic agents during their study admission. Treatment with agents affecting platelet function was avoided. Therapeutic venesection was not performed on any patient in the interval between admission to hospital and scanning after platelet labelling.
When the patients had recovered sufficiently from their exacerbation to undergo scanning, labelling of 605 Frequency of venous thrombosis in patients with an exacerbation of chronic obstructive lung disease 607 scan and death-although, as indicated above, false-negative scans probably occur occasionally. The wide variation in the interval between admission and scanning was a consequence of several factors. Platelet labelling was performed only when the patient was considered well enough to make the journey from the ward to the nuclear medicine department and to undergo the scanning procedure; thus the major factor determining the interval was the patient's speed of recovery from the exacerbation of chronic obstructive lung disease. Minor factors included the availability of indium and of scanning time. It might have been expected that deep venous thrombosis would occur more often in patients with more serious illness who were confined to bed for longer periods; but the interval between admission and scanning did not appear to influence its occurence (table) . The period of immobility and illness before admission might have influenced the development of venous thrombosis but accurate data on this period are not available. Our findings contrast with those of Prescott and colleagues,8 who found a low frequency of deep venous thrombosis in a group of North American patients with an exacerbation of chronic obstructive lung disease. Clearly major genetic and environmental differences must exist between a North American and a Scottish group of patients. In addition, the group studied by Prescott and colleagues had a lower mean age and was selected in that there had been no factors clearly precipitating the exacerbation of chronic obstructive lung disease. The criteria for admission to hospital are likely to differ between North America and Scotland; unfortunately the severity of disease in the two study populations cannot be compared from the available data. The major technique used for the diagnosis of deep venous thrombosis by Prescott and colleagues was that of ascending venography, which is noted for its accuracy in the calf but relative inaccuracy more proximally, particularly in the pelvis,9 where several of the thrombi in our patients were seen. Nevertheless, ascending venography and the indium-labelled platelet technique are both reliable methods for the diagnosis of distal thrombi and therefore the discrepancy between the findings of the two studies cannot be fully explained on the basis of the different diagnostic techniques used. Belch and her colleagues have recently observed that deep venous thrombosis, diagnosed by the iodine-131-labelled fibrinogen scanning technique, occurred in 13 of 50 (26%) Scottish patients admitted to hospital with a chest infection or cardiac failure. '0 The results of our study do not indicate when thrombi occurred in relation to the exacerbation of respiratory symptoms, and thus do not imply that venous thrombosis and pulmonary embolism contributed to events leading to hospital admission, although this remains a possibility.
This study shows that deep venous thrombosis is common in patients admitted to hospital with exacerbations of chronic obstructive lung disease. In a high proportion of those with thrombosis the thrombus is present in veins proximal to the kneethat is, in areas in which thrombi are associated with a considerably greater risk of pulmonary embolism than are thrombi that are confined to veins below the knee."
The diagnosis of pulmonary embolism is difficult in these patients, who already have abnormal pulmonary function and disturbed pulmonary perfusion and who may have pulmonary hypertension and heart failure. Furthermore, patients with severe chronic obstructive lung disease may tolerate pulmonary embolism badly. Our findings suggest that patients admitted with exacerbations may benefit from suitable prophylactic antithrombotic measures, such as low-dose subcutaneous heparin injections. '0 We are grateful to Drs JAR Friend and JS Legge for their support and permission to study their patients and to Miss Christine Wallace for typing the manuscript.
